Tuesday, June 25, 2019

MHRA recalls two batches of Paracetamol 500mg tablets

The Medicines and Healthcare products Agency (MHRA) on Thursday issued a class 2 pharmacy level medicines recall for two batches of Paracetamol 500mg tablets...

Pharma bodies demand greater ambition for community pharmacists

Three leading pharmacy bodies have called for a greater ambition around community pharmacists' role in a reformed National Health Service. At a meeting with with a...

Minority representation in NHS boardrooms halved in ten years

BY LAUREN CODLING Medical professionals have slammed the “rampant discrimination” within the NHS as a new report showed that BAME representation at senior levels is...

ABPI issues patient-centric guide for pharma companies

The Association of the British Pharmaceutical Industry (ABPI) today published a new guide for pharma companies working with patients. The guide, titled Working with patients and...

US-China trade war is opportunity for Indian drug makers

A leading data and analytics company which provides intelligence to global pharmaceutical brands says Indian drug makers should capitalise on the escalating US-China trade...

NHS fraud squad to probe pharmacy contractors

The NHS Counter Fraud Authority's priority action areas for 2019-20 include the identification of potential community pharmacy frauds. It is based on the NHS fraud...
NHS

MPs slam NHS over growing waiting list of cancer patients

Patients are being put at risk due to the continued failure of NHS to meet the waiting-time target, MPs say. A damning report by the Public Accounts...

Pharma bodies concerned about proposed HMRC tax reform

Six leading UK pharmacy bodies have warned that flexibility of the pharmacy workforce may be adversely affected if the government's proposed tax reforms were...

Genome sequencing breakthrough in diagnosis of critically ill babies

The diagnosis and treatment of some of the most critically ill babies can be improved by sequencing their whole genome, a Cambridge-based study reveals. The...

MRI scans to be trialled as test for prostate cancer

Researchers from University College London (UCL) are trialling a new prostate cancer test for men. The ReIMAGINE trial will test whether MRI scans can be used as...